Pfizer, BioNTech to test version of their COVID-19 vaccine that doesn't need ultracold storage

Pfizer and BioNtech will soon start testing a freeze-dried version of its COVID-19 vaccine that, if effective, would ease storage and handling requirements and expand access to areas without specialized equipment needed to store the vaccine, The Wall Street Journal reported March 30.